VNUS Medical Technologies to Present at William Blair & Company's 28th Annual Growth Stock Conference
More News related to VNUS
- VNUS Medical Technologies (VNUS) Makes Corrections to Q2 Earnings; Updates Guidance
- VNUS Corrects Second Quarter 2008 Results and Revises Full Year 2008 Guidance
- Pre-Open Movers 7/30: Elan (ELN) Sinks On Drug Data; Buffalo Wild Wings (BWLD) Up on Results
- VNUS Revises Upward Full-Year 2008 Net Income Guidance
- After-Hours Movers 7/29: Elan (ELN) Falls On Drug Data, MetLife (MET) Falls On Earnings/Guidance
More News related to Press Releases
- Hospitals, Healthcare Providers to Save with Premier Agreements for Blood Gas Analyzers, Reagents, Consumables, and Service
- Titan International, Inc. Announces Third Quarter Cash Dividend
- The Upcoming Technology of RFID For Contactless Access Control, Passports and Credit Cards is Too Easy to Compromise Warns Peratech
- WNS to Present at Jefferies 2nd Annual Technology Conference
- Cornerstone Schools Invite You to Be A Tiger For Kids on September 8th
SAN JOSE, Calif., June 16 /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies, Inc. (Nasdaq: VNUS), a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, today announced its plans to present at the William Blair & Company 28th Annual Growth Stock Conference, to be held June 17-19, 2008, at the Four Seasons Hotel in Chicago, IL.
VNUS' presentation is currently scheduled for 2:30 p.m. CT on Thursday, June 19, and will be webcast on the corporate website at http://ir.vnus.com/events.cfm. The management speaker will be Brian Farley, President and Chief Executive Officer. An archive of the webcast will be available through July 19.
About VNUS Medical Technologies, Inc.
VNUS is a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, a progressive condition that is often the underlying cause of painful varicose veins. VNUS sells the Closure(R) system, which consists of a proprietary radiofrequency (RF) generator and proprietary disposable endovenous catheters and devices to close diseased veins through the application of temperature-controlled RF energy. Approximately 300,000 patients have been treated to date with VNUS Closure catheters. For more information, please visit the corporate website at http://www.vnus.com .
SOURCE VNUS Medical Technologies, Inc.
Related Categories
Press ReleasesStocks Mentioned
-0.89Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
